CYCLERION THERAPEUTICS, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount
CYCLERION THERAPEUTICS, INC. (CYCN) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount of $571.00 thousand for the 12-month period ending 2025-12-31, per its S-4/A filed 2026-07-22.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpense · last filed 2026-07-22
- CYCLERION THERAPEUTICS, INC. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2023 was $1.00K, a 92.86% decline from fiscal 2022.
- CYCLERION THERAPEUTICS, INC. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2022 was $14.00K.
- CYCLERION THERAPEUTICS, INC. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2021 was -$420.00K.
- CYCLERION THERAPEUTICS, INC. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2020 was -$94.00K, a 106.15% decline from fiscal 2019.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $571.00K S-4/A · filed 2026-07-22 | |
| 2024-12-31 | $88.00K S-4/A · filed 2026-07-22 | -$4.00K 10-K · filed 2025-03-04 |
| 2023-12-31 | $1.00K 10-K/A · filed 2025-11-12 | |
| 2022-12-31 | $14.00K 10-K · filed 2024-03-05 | |
| 2021-12-31 | -$420.00K 10-K · filed 2023-03-22 | |
| 2020-12-31 | -$94.00K 10-K · filed 2022-02-24 | |
| 2019-12-31 | $1.53M 10-K · filed 2021-02-25 | |
| 2018-12-31 | $40.00K 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |